Observed to expected ratios of clinical trial enrollment compared to hemophilia and general census populations
| . | White . | Black . | Hispanic . | Asian . |
|---|---|---|---|---|
| OER ratio (95% CI) . | OER ratio (95% CI) . | OER ratio (95% CI) . | OER ratio (95% CI) . | |
| US HTCs | 0.83 (0.80-0.86) | 0.34 (0.15-0.78) | 0.29 (0.16-0.54) | — |
| US census | 0.85 (0.82-0.87) | 0.24 (0.11-0.50) | 0.27 (0.15-0.48) | 3.65 (3.08-4.32) |
| UK census | 0.80 (0.78-0.82) | 0.97 (0.43-2.20) | — | 2.43 (2.10-2.82) |
| Canada census | 0.91 (0.88-0.94) | 0.90 (0.40-2.03) | — | 1.64 (1.43-1.88) |
| Brazil census | 1.37 (1.33-1.41) | 0.51 (0.24-1.11) | — | — |
| . | White . | Black . | Hispanic . | Asian . |
|---|---|---|---|---|
| OER ratio (95% CI) . | OER ratio (95% CI) . | OER ratio (95% CI) . | OER ratio (95% CI) . | |
| US HTCs | 0.83 (0.80-0.86) | 0.34 (0.15-0.78) | 0.29 (0.16-0.54) | — |
| US census | 0.85 (0.82-0.87) | 0.24 (0.11-0.50) | 0.27 (0.15-0.48) | 3.65 (3.08-4.32) |
| UK census | 0.80 (0.78-0.82) | 0.97 (0.43-2.20) | — | 2.43 (2.10-2.82) |
| Canada census | 0.91 (0.88-0.94) | 0.90 (0.40-2.03) | — | 1.64 (1.43-1.88) |
| Brazil census | 1.37 (1.33-1.41) | 0.51 (0.24-1.11) | — | — |